
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of Prostate Cancer in Older Adults
Laura Graham, John K. Lin, Daniel E. Lage, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 22
Laura Graham, John K. Lin, Daniel E. Lage, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 22
Showing 22 citing articles:
circDHX33 suppresses glycolysis, malignant proliferation, and metastasis in prostate cancer by interacting with RNA-binding protein IGF2BP2 to destabilize its protein
Xiangdong Liang, Xiaoliang Tan, Long Pei, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Xiangdong Liang, Xiaoliang Tan, Long Pei, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Are Evidence-Based Guidelines Translating into Clinical Practice? A National Population-Based Study of the Use of Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in England
Joanna Dodkins, Adrian Cook, E. E. Mayne, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115335-115335
Open Access
Joanna Dodkins, Adrian Cook, E. E. Mayne, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115335-115335
Open Access
MSI1 Accelerates Prostate Cancer Cell Proliferation, Migration and Glycolysis by Promoting ABHD2 Transcription
Dingping Huang, Qing-qi Zheng, Liying Zhou
Biochemical Genetics (2025)
Closed Access
Dingping Huang, Qing-qi Zheng, Liying Zhou
Biochemical Genetics (2025)
Closed Access
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line
Giovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Giovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Open Access
Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC
Ángel Borque‐Fernando, Teresa Alonso‐Gordoa, María José Juan-Fita, et al.
Future Oncology (2025), pp. 1-13
Open Access
Ángel Borque‐Fernando, Teresa Alonso‐Gordoa, María José Juan-Fita, et al.
Future Oncology (2025), pp. 1-13
Open Access
Exploration of cardiac adverse events associated with relugolix and degarelix: a multi-center pharmacovigilance study based on the FAERS database
Meina Lv, Jianhui Chen, Bin Zheng, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Meina Lv, Jianhui Chen, Bin Zheng, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
Deborah R. Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 381-391
Open Access | Times Cited: 3
Deborah R. Kaye, Ibrahim Khilfeh, Erik Muser, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 381-391
Open Access | Times Cited: 3
Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
Kamil Malshy, Anna Ochsner, Alexander Homer, et al.
The Prostate (2024) Vol. 84, Iss. 13, pp. 1209-1217
Closed Access | Times Cited: 3
Kamil Malshy, Anna Ochsner, Alexander Homer, et al.
The Prostate (2024) Vol. 84, Iss. 13, pp. 1209-1217
Closed Access | Times Cited: 3
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
Corbin Eule, Elizabeth Molina Kuna, Tyler P. Robin, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 12, pp. 447.e17-447.e24
Open Access | Times Cited: 2
Corbin Eule, Elizabeth Molina Kuna, Tyler P. Robin, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 12, pp. 447.e17-447.e24
Open Access | Times Cited: 2
Personalization in digital health interventions for older adults with cancer: A scoping review
Misun Hwang, Yun Jiang
Journal of Geriatric Oncology (2023) Vol. 14, Iss. 8, pp. 101652-101652
Closed Access | Times Cited: 4
Misun Hwang, Yun Jiang
Journal of Geriatric Oncology (2023) Vol. 14, Iss. 8, pp. 101652-101652
Closed Access | Times Cited: 4
Frailty in Older Adults with Prostate Cancer
Neha Pathak, Efthymios Papadopoulos, Vikaash Kumar, et al.
European Urology Oncology (2024)
Open Access | Times Cited: 1
Neha Pathak, Efthymios Papadopoulos, Vikaash Kumar, et al.
European Urology Oncology (2024)
Open Access | Times Cited: 1
Biochemical Recurrence in Prostate Cancer — Tilting the Scale
Ana Aparicio
New England Journal of Medicine (2023) Vol. 389, Iss. 16, pp. 1522-1523
Closed Access | Times Cited: 2
Ana Aparicio
New England Journal of Medicine (2023) Vol. 389, Iss. 16, pp. 1522-1523
Closed Access | Times Cited: 2
Common biological factors implicated in benign prostatic hyperplasia and prostate cancer, conventional and phytotherapeutic approaches employed in management: A review
Gift Crucifix Pender, James H Ombaka, Peter Mwitari, et al.
International Journal of Science and Research Archive (2023) Vol. 11, Iss. 2, pp. 049-074
Open Access | Times Cited: 2
Gift Crucifix Pender, James H Ombaka, Peter Mwitari, et al.
International Journal of Science and Research Archive (2023) Vol. 11, Iss. 2, pp. 049-074
Open Access | Times Cited: 2
Systemic therapy of prostate cancer in elderly patients
Gunhild von Amsberg, Tobias Busenbender, Derya Tilki, et al.
Deleted Journal (2024) Vol. 30, Iss. 2, pp. 119-128
Closed Access
Gunhild von Amsberg, Tobias Busenbender, Derya Tilki, et al.
Deleted Journal (2024) Vol. 30, Iss. 2, pp. 119-128
Closed Access
Surgical Outcome of Open Radical Prostatectomy in Nigeria: A Five-Years Single-Surgeon Experience
S O Osaghae
Nigerian Journal of Clinical Practice (2024) Vol. 27, Iss. 5, pp. 570-575
Closed Access
S O Osaghae
Nigerian Journal of Clinical Practice (2024) Vol. 27, Iss. 5, pp. 570-575
Closed Access
Development and Validation of a Clinic Machine Learning Classifier for the Prediction of Risk Stratifications of Prostate Cancer Bone Metastasis Progression to Castration Resistance
Xin Li, Peng Cui, Xingxing Zhao, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2821-2831
Open Access
Xin Li, Peng Cui, Xingxing Zhao, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2821-2831
Open Access
Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor
Yulin Wu, Yan‐Fang Xian, Juan Zhang, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 3
Closed Access
Yulin Wu, Yan‐Fang Xian, Juan Zhang, et al.
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 3
Closed Access
Understanding Prostate Cancer: Pathogenesis, Risk Factors, and Early Detection
Sikhumbuzo Z. Mbatha, Thabiso Victor Miya, Elisa M. Ledet, et al.
(2024), pp. 27-43
Closed Access
Sikhumbuzo Z. Mbatha, Thabiso Victor Miya, Elisa M. Ledet, et al.
(2024), pp. 27-43
Closed Access
Unveiling the molecular profile of a prostate carcinoma: implications for personalized medicine
Massimiliano Agostini, Erica Giacobbi, Francesca Servadei, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Massimiliano Agostini, Erica Giacobbi, Francesca Servadei, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Management considerations and treatment outcomes for newly diagnosed prostate cancer in advanced age patients (≥80 years): real-world data from a single urological center over a 10-year period
Xiong Xiao, J Wang, Yong Wang, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 8, pp. 1506-1516
Open Access
Xiong Xiao, J Wang, Yong Wang, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 8, pp. 1506-1516
Open Access
Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression
Élisa Carouge, Clémence Burnichon, Martin Figeac, et al.
Molecular Oncology (2024)
Open Access
Élisa Carouge, Clémence Burnichon, Martin Figeac, et al.
Molecular Oncology (2024)
Open Access
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line
Giovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
Research Square (Research Square) (2024)
Closed Access
Giovanni Tossetta, Sonia Fantone, Elena Marinelli Busilacchi, et al.
Research Square (Research Square) (2024)
Closed Access